6 GLP-1 Risks That Hit Harder After 65 — Just As Medicare Starts Paying
Starting July 1, Medicare began covering weight-loss drugs like Wegovy and Zepbound for a $50 monthly copay. For seniors who’d ...
Monday, September 21, 2026
Tag: GLP1
Medicare’s New GLP-1 Weight Loss Program Is Complicated but Worth It
Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. ...
The $50 GLP-1 Bridge: How to Get Affordable Weight-Loss Meds Starting July 1
Beginning July 1, qualifying Medicare recipients will be able to take weight-loss drugs for $50 per month through the new ...
Research Shows GLP-1 Weight-Loss Drugs May Weaken Bones — What Older Adults Should Ask Their Doctor
Around 9% of adults in the United States (65 and older) have reportedly used GLP-1s like Ozempic and Wegovy. As ...
GLP-1 Coverage Update: How Medicare’s New Transitional Policies Could Lower Out-of-Pocket Costs for Weight-Loss Medications
For years, many seniors and retirees have faced a frustrating reality: popular GLP-1 medications like Wegovy and Zepbound could cost ...
Amazon Launches Nationwide GLP-1 Weight-Loss Program
Amazon is rolling out a new GLP-1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to ...
Foundayo, Wegovy and How GLP-1 Weight-Loss Pills Compare to Shots
As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles now have two options in pill form ...
GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics
As several Indian pharma giants race to launch cheaper generics for Semaglutide, the active ingredient in popular weight-loss drugs Ozempic ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.